CHTOP and ovarian carcinoma: Our data indicate that CHTOP overexpression is associated with a poor prognosis in ovarian cancer patients and an enhanced phenotype of metastasis, chemoresistance, and stemness in epithelial ovarian cancer cells, highlighting the potential of CHTOP as a novel therapeutic target in dealing with ovarian cancer.